May 17, 2024
Updates to the Master List and Required Prior Authorization List Effective August 12, 2024
On May 13, 2024, CMS announced updates to the Master List and the Required Prior Authorization List.
DMEPOS Suppliers need to be aware of the following changes that will start on August 12, 2024:
- Orthoses:
- Effective August 12, 2024, Medicare will not require prior authorization and face-to-face encounter and Written Order Prior to Delivery (WOPD) for HCPCS code L1833.
- CMS selected six more orthoses codes (L0631, L0637, L0639, L1843, L1845, L1951) for required prior authorization to begin nationwide on August 12, 2024.
- Osteogenesis Stimulators:
- CMS selected three HCPCS codes (E0747, E0748, E0760) subject to required prior authorization.
- There will be two phases of implementation:
- Phase one begins August 12, 2024, in California, Florida, Ohio, and Pennsylvania.
- Phase two begins November 12, 2024, in all remaining states and territories not included in phase 1.